3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
7
Breast Neoplasms
7
Head and Neck Neoplasms
5
Glioblastoma
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Melanoma
3
Hematologic Neoplasms
3
Glioma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Lymphedema
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Tongue Neoplasms
1
Spinal Cord Neoplasms
1
Smoking Cessation
1
Smoking
1
Signs and Symptoms, Digestive
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Interventions
Echocardiography
14
Doxorubicin
10
Exercise
8
Electrocardiography
7
Trastuzumab
6
Cyclophosphamide
5
Carvedilol
5
Docetaxel
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Magnetic Resonance Spectroscopy
2
Ivabradine
2
High-Intensity Interval Training
2
Exercise Test
2
Chemoradiotherapy
2
Blood Specimen Collection
2
Bisoprolol
2
Antineoplastic Agents
2
Anthracyclines
2
sulforaphane
1
schizandrin
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
mitoquinone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cardiotoxicity
×
Restraint, Physical
×
Clear all
NCT02571894
2018-03-07
COBC
Karolinska University Hospital
Phase NA
Unknown
320 enrolled